242 related articles for article (PubMed ID: 29502924)
21. Clinical requirements for closed-loop control systems.
Clarke WL; Renard E
J Diabetes Sci Technol; 2012 Mar; 6(2):444-52. PubMed ID: 22538159
[TBL] [Abstract][Full Text] [Related]
22. Insulin pump therapy in pregnant women with type 1 diabetes mellitus.
Roman G
Rom J Intern Med; 2004; 42(2):465-8. PubMed ID: 15529637
[No Abstract] [Full Text] [Related]
23. ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed.
Klonoff DC
J Diabetes Sci Technol; 2014 May; 8(3):439-43. PubMed ID: 24876603
[No Abstract] [Full Text] [Related]
24. Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements.
Zisser HC; Bailey TS; Schwartz S; Ratner RE; Wise J
J Diabetes Sci Technol; 2009 Sep; 3(5):1146-54. PubMed ID: 20144429
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.
Leelarathna L; Nodale M; Allen JM; Elleri D; Kumareswaran K; Haidar A; Caldwell K; Wilinska ME; Acerini CL; Evans ML; Murphy HR; Dunger DB; Hovorka R
Diabetes Technol Ther; 2013 Feb; 15(2):143-9. PubMed ID: 23256605
[TBL] [Abstract][Full Text] [Related]
26. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
[TBL] [Abstract][Full Text] [Related]
27. A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes.
Jafri RZ; Balliro CA; El-Khatib F; Maheno MM; Hillard MA; O'Donovan A; Selagamsetty R; Zheng H; Damiano ER; Russell SJ
Diabetes Technol Ther; 2020 Nov; 22(11):846-852. PubMed ID: 32453604
[No Abstract] [Full Text] [Related]
28. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
Ziegler R; Eichholz R; Schulz B
J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
[TBL] [Abstract][Full Text] [Related]
29. Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor.
Boscari F; Vettoretti M; Amato AML; Vallone V; Uliana A; Iori E; Avogaro A; Facchinetti A; Bruttomesso D
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):650-657. PubMed ID: 33594987
[TBL] [Abstract][Full Text] [Related]
30. Flash Continuous Glucose Monitoring (FreeStyle Libre 14-Day System) for Self-Management of Diabetes Mellitus.
Choi HYJ
Am Fam Physician; 2021 Jun; 103(11):688-690. PubMed ID: 34060782
[No Abstract] [Full Text] [Related]
31. Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.
Tauschmann M; Thabit H; Leelarathna L; Elleri D; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2015 Oct; 9(6):1346-7. PubMed ID: 26451010
[No Abstract] [Full Text] [Related]
32. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
33. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age.
Tsoukas M; Rutkowski J; El-Fathi A; Yale JF; Bernier-Twardy S; Bossy A; Pytka E; Legault L; Haidar A
Diabetes Technol Ther; 2020 Mar; 22(3):203-207. PubMed ID: 31613140
[No Abstract] [Full Text] [Related]
35. Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System.
Felício KM; de Souza ACCB; Neto JFA; de Melo FTC; Carvalho CT; Arbage TP; de Rider Brito HA; Peixoto AS; de Oliveira AF; de Souza Resende F; Reis SS; Motta AR; da Costa Miranda H; Janau LC; Yamada ES; Felicio JS
Curr Diabetes Rev; 2018; 14(4):395-403. PubMed ID: 28618984
[TBL] [Abstract][Full Text] [Related]
36. Real-world outcomes with different technology modalities in type 1 diabetes.
Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
[TBL] [Abstract][Full Text] [Related]
37. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
[TBL] [Abstract][Full Text] [Related]
38. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
[TBL] [Abstract][Full Text] [Related]
39. An analysis of the SEVEN system: have we reached the summit of needle-type sensor accuracy?
Wentholt IM; DeVries JH
J Diabetes Sci Technol; 2009 Sep; 3(5):1155-7. PubMed ID: 20144430
[TBL] [Abstract][Full Text] [Related]
40. Deus ex machina: the use of technology in type 1 diabetes.
Kerr D; Partridge H
Prim Care Diabetes; 2011 Oct; 5(3):159-65. PubMed ID: 21727052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
